We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+14.57%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$6.85B
AUM Growth
-$481M
Cap. Flow
-$845M
Cap. Flow %
-12.34%
Top 10 Hldgs %
41.03%
Holding
120
New
33
Increased
27
Reduced
18
Closed
27

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$376M
2
AGN
Allergan plc
AGN
+$262M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$213M
4
HSP
HOSPIRA INC
HSP
+$179M
5
SIAL
SIGMA - ALDRICH CORP
SIAL
+$160M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$531M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$460M
3
SWY
SAFEWAY INC
SWY
+$318M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$258M
5
ROC
ROCKWOOD HLDGS INC
ROC
+$184M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.56%
2 Healthcare 10.46%
3 Industrials 10.4%
4 Technology 9.5%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GAME
101
DELISTED
SHANDA GAMES LTD SPON ADR REPSTG CL A (CAYMAN ISLANDS)
GAME
– –
-1,229,493
Closed -$6.98M
CFN
102
DELISTED
CAREFUSION CORPORATION
CFN
– –
-2,440,000
Closed -$145M
CODE
103
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
– –
-886,659
Closed -$30.3M
PETM
104
DELISTED
PETSMART INC
PETM
– –
-125,000
Closed -$10.2M
CVD
105
DELISTED
COVANCE INC.
CVD
– –
-254,000
Closed -$26.4M
TRLA
106
DELISTED
TRULIA INC (DEL)
TRLA
– –
-50,000
Closed -$2.3M
DRIV
107
DELISTED
DIGITAL RIVER INC.
DRIV
– –
-218,172
Closed -$5.39M
SAPE
108
DELISTED
SAPIENT CORP
SAPE
– –
-615,000
Closed -$15.3M
SWY
109
DELISTED
SAFEWAY INC
SWY
– –
-9,053,900
Closed -$318M
AUXL
110
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-2,455,000
Closed -$84.4M
CBST
111
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-2,565,000
Closed -$258M
HCT
112
DELISTED
AMRICAN RLTY CAP HEALTHCARE TRUST INC. COMMON STOCK
HCT
– –
-7,405,000
Closed -$88.1M
ROC
113
DELISTED
ROCKWOOD HLDGS INC
ROC
– –
-2,330,000
Closed -$184M
COV
114
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
– –
-4,500,000
Closed -$460M
AMFW
115
DELISTED
AMEC Foster Wheeler plc
AMFW
– –
-1,732,342
Closed -$22.4M
AGN
116
DELISTED
Allergan Inc
AGN
– –
-2,498,000
Closed -$531M
1 2 3 4
5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2015 Portfolio in Review

As of Q1 2015, Thomas Steyer held 120 positions worth $6.85B, down 6.6% from $7.33B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Thomas Steyer withdrew a net $845M in Q1 2015, closing 27 positions and reducing 18 holdings. Its most notable exit was Allergan Inc, an estimated $531M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Thomas Steyer opened a new position in PHARMACYCLICS INC worth $498M.

  • Thomas Steyer's largest Q1 2015 buy was PHARMACYCLICS INC: 1,945,000 shares worth $498M.
  • Thomas Steyer added most to Allergan plc in Q1 2015, an estimated $262M increase.
  • Thomas Steyer's biggest Q1 2015 reduction was Coca-Cola Europacific Partners, cutting an estimated $123M.
  • Thomas Steyer fully exited Allergan Inc in Q1 2015, selling an estimated $531M.
  • Thomas Steyer's ten largest holdings make up 41% of its $6.85B portfolio in Q1 2015.
  • Thomas Steyer opened 33 new positions and closed 27 in Q1 2015.
  • Thomas Steyer's portfolio value fell 6.6% quarter-over-quarter to $6.85B.

Based on Farallon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.